Genetic and molecular basis for copper toxicity

American Journal of Clinical Nutrition

Volumn 63, Issue 5, 1996, Pages

  Leah Harris, Z ^a   Gitlin, Jonathan D ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

aceruloplasminemia; Copper; iron; Wilson disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CERULOPLASMIN; COPPER;

COPPER METABOLISM; GENE MUTATION; HUMAN; INTOXICATION; MENKES SYNDROME; METABOLIC DISORDER; MOLECULAR GENETICS; REVIEW; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; AMINO ACID SEQUENCE; ANIMALS; CERULOPLASMIN; COPPER; DISEASE MODELS, ANIMAL; HEPATOLENTICULAR DEGENERATION; HUMANS; MENKES KINKY HAIR SYNDROME; MOLECULAR SEQUENCE DATA; MUTATION; RATS;

EID: 15844384254     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Bremner I, Beattie JH. Metallothionein and the trace minerals. Annu Rev Nutr 1990;10:63-83.
2. Cousins RJ. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 1985;65:238-309.
3. Winge DR, Mehra RK. Host defenses against copper toxicity. Int Rev Exp Pathol 1990;31:47-83.
4. Gitlin D, Janeway CA. Turnover of the copper and protein moieties of ceruloplasmin. Nature 1960;185:693.
5. Sternlieb I, Scheinberg IH. The role of radiocopper in the diagnosis of Wilson's disease. Gastroenterology 1979;77 138-42.
6. Kodama H. Recent developments in Menkes disease. J Inherit Metab Dis 1993;16.791-9.
7. Mercer JF, Livingston J, Hall B, et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nature Genet 1993;3: 3-4.
8. Chelly J, Turner Z, Tonnesen T, et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nature Genet 1993;3:14-9.
9. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nature Genet 1993;3:7-13.
10. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993;197:271-7.
11. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene Nature Genet 1993;5:327-37.
12. Tanzi RE, Petrukhin K, Chemov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genet 1993,5:344-50.
13. Solioz M, Odermatt A, Krapf R. Copper pumping ATPases: common concepts in bacteria and man. FEBS Lett 1994;346:44-7.
14. Odermatt A, Suter H, Krapf R, Solioz M. Primary structure of two P-type ATPases involved in copper homeostasis in Enterococcus hirae. J Biol Chem 1993;268:12775-9.
15. Phung LT, Ajlani G, Haselkom R. P-type ATPase from the cyanobacterium Synchococcus 7942 related to the human Menkes and Wilson disease gene products. Proc Natl Acad Sci U S A 1994;91:9651-4
16. Kanamaru K, Kashiwagi IS, Mizuno T. A copper-transporting P-type ATPase found in the thylakoid membrane of the cyanobacterium Synchococcus species PCC7942. Mol Microbiol 1994;13:369-77.
17. Ge ZM, Hiratsuka K, Taylor DE. Nucleotide sequence and mutational analysis indicate that two Helicobacter pylori genes encode a P-type ATPase and a cation-binding protein associated with copper transport Mol Microbiol 1995;15:97-106.
18. 2+-transporting ATPase gene on chromosome II of Saccharomyces cerevisiae. Yeast 1994;10:1217-25.
19. Petrukhin K, Lutsenko S, Chemov I, Ross BM, Kaplan JH, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function preditions. Hum Mol Genet 1994;3:1647-56.
20. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nature Genet 1995;9:210-7.
21. Kaler SG, Gallo LK, Proud VK, et al. Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nature Genet 1994;8:195-202.
22. Das S, Levinson B, Whitney S, Vulpe C, Packman S, Gitschier J. Diverse mutations in patients with Menkes disease often lead to exon skipping. Am J Hum Genet 1994;55:883-9.
23. Dijkstra M, In't Veld G, van den Berg GJ, Muller M, Kuipers F, Vonk RJ. Adenosine triphosphate-dependent copper transport in isolated rat liver plasma membranes. J Clin Invest 1995;95:412-6.
24. Rosen DR, Siddique T, Petterson A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
25. Li Y, Togashi Y, Sato S, et al. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J Clin Invest 1991;87:1858-61.
26. Yamada T, Agui T, Suzuki Y, Sato M, Matsumoto K. Inhibition of the copper incorporation into ceruloplasmin leads to the deficiency in serum ceruloplasmin activity in Long-Evans Cinnamon mutant rat. J Biol Chem 1993;268:8965-71.
27. Yamaguchi Y, Heiny ME, Shimizu N, Aoki T, Gitlin JD. Expression of the Wilson disease gene is deficient in the Long-Evans Cinnamon rat. Biochem J 1994;301.1-4.
28. Wu J, Forbes JR, Chen HS, Cox DW. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nature Genet 1994;7:541-5.
29. Masuda R, Yoshida MC, Sasaki M, Dempo K, Mon M. High susceptibility to hepatocelular carcinoma development in LEC rats with hereditary hepatitis. Jpn J Cancer Res 1992;79:828-35.
30. Jong-Hon K, Togashi Y, Kasai H, Hosokawa M, Takeichi N. Prevention of spontaneous hepatocellular carcinoma in Long-Evans Cinnamon rats with hereditary hepatitis by the administration of D-penicillamine. Hepatology 1993;18:614-20.
31. Holmberg CG, Laurell CB, Investigations in serum copper. II. Isolation of the copper containing protein, and a description of some of its properties. Clin Chim Acta 1948;2:550-6.
32. Cumings JN. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 1948;71:410-5.
33. Scheinberg IH, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 1952;116: 484-94.
34. Cox DW. Factors influencing serum ceruloplasmin levels in normal individuals. J Lab Clin Med 1966;68:893-904.
35. Takahashi N, Ortel TL, Putnam FW. Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule. Proc Natl Acad Sci U S A 1984;81:390-4.
36. Gitlin JD, Schroeder JJ, Lee-Ambrose LM, Cousins RJ. Mechanisms of ceruloplasmin biosynthesis in normal and copper-deficient rat. Biochem J 1992;282:835-9.
37. Sato M, Gitlin JD. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem 1991;266:5128-34.
38. Hiyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987;37:761-7.
39. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GP. Hereditary caerulopaslmin deficiency, dementia and diabetes. Q J Med 1994;87:663-70.
40. Morita H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995;37.646-56.
41. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RTA, Gitlin JD. Aceruloplasminemia: molecular characterization of a novel disorder of iron metabolism. Proc Natl Acad Sci U S A 1995; 92:2539-43.
42. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genet 1995;43:267-72.
43. Takahashi Y, Miyajima H, Shirake T, Suenaga A, Gitlin JD. A novel mutation resulting in aceruloplasminemia. Hum Molec Genet 1996;5: 81-4.
44. Hart EB, Steenbock H, Waddell J, Elvehjem CA. Iron in nutrition. Copper as a supplement to iron for hemoglobin building in the rat. J Biol Chem 1928;77:797-812.
45. Roeser HP, Lee GR, Nacht S, Cartwright GE. The role of ceruloplasmin in iron metabolism. J Clin Invest 1970;49:2408-17.
46. Osaki S, Johnson DA, Frieden E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J Biol Chem 1971;246:3018-23.
47. Dancis A, Yuan DS, Haile D, et al. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell 1994;76:393-402.
48. Tomac A, Lindquist E, Lin H, et al. Protection and repair of the nigrostriatal dopaminergic system by DGNF in vivo. Nature 1995;373: 335-9.
49. Beck KD, Valverde J, Alexi T, et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995;373:339-41.
50. Oppenheim RW, Houenou LJ, Johnson JE, et al. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 1995;373:344-6.
51. Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793-807.
52. Gurney ME, Pu H, Chiu AY, et al. Motor neurodegeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994,264:1772-5.
53. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 1995;92:689-93.